AfovirsenAlternative Names: IP 2105; ISIS 2105
Latest Information Update: 25 Jan 1996
At a glance
- Originator Isis Pharmaceuticals
- Class Antivirals; Nucleosides
- Mechanism of Action Protein synthesis inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Cancer; Human papillomavirus infections